501 related articles for article (PubMed ID: 28055956)
1. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
2. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer.
Zheng B; Peng M; Gong J; Li C; Cheng H; Li Y; Tang Y
Exp Biol Med (Maywood); 2023 Aug; 248(16):1403-1413. PubMed ID: 37551102
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy.
Li LL; Qu LL; Fu HJ; Zheng XF; Tang CH; Li XY; Chen J; Wang WX; Yang SX; Wang L; Zhao GH; Lv PP; Zhang M; Lei YY; Qin HF; Wang H; Gao HJ; Liu XQ
Oncotarget; 2017 Jul; 8(28):45399-45414. PubMed ID: 28514730
[TBL] [Abstract][Full Text] [Related]
4. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer.
Zhou C; Chen Z; Zhao L; Zhao W; Zhu Y; Liu J; Zhao X
J Clin Lab Anal; 2020 Nov; 34(11):e23505. PubMed ID: 33463758
[TBL] [Abstract][Full Text] [Related]
5. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients.
Szpechcinski A; Florczuk M; Duk K; Zdral A; Rudzinski S; Bryl M; Czyzewicz G; Rudzinski P; Kupis W; Wojda E; Giedronowicz D; Langfort R; Barinow-Wojewodzki A; Orlowski T; Chorostowska-Wynimko J
Cell Mol Life Sci; 2019 Sep; 76(18):3641-3656. PubMed ID: 30953094
[TBL] [Abstract][Full Text] [Related]
6. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer.
Cazzoli R; Buttitta F; Di Nicola M; Malatesta S; Marchetti A; Rom WN; Pass HI
J Thorac Oncol; 2013 Sep; 8(9):1156-62. PubMed ID: 23945385
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.
Dinh TK; Fendler W; Chałubińska-Fendler J; Acharya SS; O'Leary C; Deraska PV; D'Andrea AD; Chowdhury D; Kozono D
Radiat Oncol; 2016 Apr; 11():61. PubMed ID: 27117590
[TBL] [Abstract][Full Text] [Related]
8. Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.
Nigita G; Distefano R; Veneziano D; Romano G; Rahman M; Wang K; Pass H; Croce CM; Acunzo M; Nana-Sinkam P
Sci Rep; 2018 Jul; 8(1):10222. PubMed ID: 29976955
[TBL] [Abstract][Full Text] [Related]
9. Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer.
Kim DH; Park H; Choi YJ; Im K; Lee CW; Kim DS; Pack CG; Kim HY; Choi CM; Lee JC; Ji W; Rho JK
Biomark Res; 2023 Sep; 11(1):80. PubMed ID: 37705067
[TBL] [Abstract][Full Text] [Related]
10. Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer.
Wang Y; Gu J; Roth JA; Hildebrandt MA; Lippman SM; Ye Y; Minna JD; Wu X
Cancer Res; 2013 Aug; 73(15):4801-9. PubMed ID: 23774211
[TBL] [Abstract][Full Text] [Related]
11. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.
Taverna S; Giallombardo M; Gil-Bazo I; Carreca AP; Castiglia M; Chacártegui J; Araujo A; Alessandro R; Pauwels P; Peeters M; Rolfo C
Oncotarget; 2016 May; 7(19):28748-60. PubMed ID: 26919248
[TBL] [Abstract][Full Text] [Related]
12. Serum Exosomal MicroRNAs Predict Acute Respiratory Distress Syndrome Events in Patients with Severe Community-Acquired Pneumonia.
Wu X; Wu C; Gu W; Ji H; Zhu L
Biomed Res Int; 2019; 2019():3612020. PubMed ID: 31467883
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of circulating exosomal miRNAs in multiple myeloma.
Manier S; Liu CJ; Avet-Loiseau H; Park J; Shi J; Campigotto F; Salem KZ; Huynh D; Glavey SV; Rivotto B; Sacco A; Roccaro AM; Bouyssou J; Minvielle S; Moreau P; Facon T; Leleu X; Weller E; Trippa L; Ghobrial IM
Blood; 2017 Apr; 129(17):2429-2436. PubMed ID: 28213378
[TBL] [Abstract][Full Text] [Related]
14. Exosomal microRNAs are novel circulating biomarkers in cigarette, waterpipe smokers, E-cigarette users and dual smokers.
Singh KP; Maremanda KP; Li D; Rahman I
BMC Med Genomics; 2020 Sep; 13(1):128. PubMed ID: 32912198
[TBL] [Abstract][Full Text] [Related]
15. Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.
Hou LK; Ma YS; Han Y; Lu GX; Luo P; Chang ZY; Xie RT; Yang HQ; Chai L; Cai MX; Wu TM; Yu F; Qin SS; Lv ZW; Wu CY; Fu D
PLoS One; 2017; 12(1):e0170431. PubMed ID: 28141816
[TBL] [Abstract][Full Text] [Related]
16. Plasma exosomal
Chen L; Wang K; Li L; Zheng B; Zhang Q; Zhang F; Chen J; Wang S
Future Oncol; 2022 Aug; 18(26):2919-2931. PubMed ID: 35893704
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of plasma microRNAs for non-small cell lung cancer based on data mining models.
Yan M; Kang W; Liu X; Yang B; Sun N; Yang Y; Wang W
BMC Cancer; 2024 Jan; 24(1):52. PubMed ID: 38200421
[TBL] [Abstract][Full Text] [Related]
18. A test of miR-128-3p and miR-33a-5p in serum exosome as biomarkers for auxiliary diagnosis of non-small cell lung cancer.
Li M; Liu T; Cheng W; Jin H; Wang X
J Thorac Dis; 2023 May; 15(5):2616-2626. PubMed ID: 37324093
[TBL] [Abstract][Full Text] [Related]
19. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
Lai X; Wang M; McElyea SD; Sherman S; House M; Korc M
Cancer Lett; 2017 May; 393():86-93. PubMed ID: 28232049
[TBL] [Abstract][Full Text] [Related]
20. Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer.
Liu J; Yoo J; Ho JY; Jung Y; Lee S; Hur SY; Choi YJ
J Ovarian Res; 2021 Apr; 14(1):59. PubMed ID: 33910598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]